Header Logo

Connection

LORETTA NASTOUPIL to Administration, Intravenous

Back to Details
This is a "connection" page, showing publications LORETTA NASTOUPIL has written about Administration, Intravenous.
LORETTA NASTOUPIL
Connection Strength
0.048
Administration, Intravenous
  1. Single-Agent Mosunetuzumab Shows Durable Complete Responses in Patients With Relapsed or Refractory B-Cell Lymphomas: Phase I Dose-Escalation Study. J Clin Oncol. 2022 02 10; 40(5):481-491.
    View in: PubMed
    Score: 0.048
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.